Scotia Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.75M | Buy |
49,891
+532
| +1% | +$28.8K | 0.01% | 398 |
|
|
2025
Q4 | $2.42M | Sell |
49,359
-2,748
| -5% | -$128K | 0.01% | 420 |
|
|
2025
Q3 | $2.25M | Sell |
52,107
-5,982
| -10% | -$234K | 0.01% | 428 |
|
|
2025
Q2 | $2.23M | Sell |
58,089
-10,946
| -16% | -$418K | 0.01% | 404 |
|
|
2025
Q1 | $2.67M | Sell |
69,035
-3,117
| -4% | -$114K | 0.01% | 362 |
|
|
2024
Q4 | $2.44M | Sell |
72,152
-4,248
| -6% | -$153K | 0.01% | 374 |
|
|
2024
Q3 | $3.12M | Sell |
76,400
-3,463
| -4% | -$142K | 0.02% | 336 |
|
|
2024
Q2 | $3.07M | Sell |
79,863
-2,065
| -3% | -$86.9K | 0.02% | 326 |
|
|
2024
Q1 | $3.51M | Sell |
81,928
-1,061
| -1% | -$43.8K | 0.02% | 301 |
|
|
2023
Q4 | $3.08M | Sell |
82,989
-11,064
| -12% | -$397K | 0.02% | 299 |
|
|
2023
Q3 | $3.41M | Sell |
94,053
-2,462
| -3% | -$87.4K | 0.02% | 271 |
|
|
2023
Q2 | $3.44M | Buy |
96,515
+5,911
| +7% | +$212K | 0.02% | 277 |
|
|
2023
Q1 | $3.22M | Buy |
90,604
+33,066
| +57% | +$1.16M | 0.02% | 284 |
|
|
2022
Q4 | $2.02M | Buy |
57,538
+4,522
| +9% | +$151K | 0.02% | 346 |
|
|
2022
Q3 | $1.56M | Sell |
53,016
-670
| -1% | -$25.4K | 0.01% | 383 |
|
|
2022
Q2 | $2.92M | Sell |
53,686
-29,417
| -35% | -$1.62M | 0.02% | 305 |
|
|
2022
Q1 | $4.53M | Buy |
83,103
+2,671
| +3% | +$145K | 0.03% | 272 |
|
|
2021
Q4 | $4.43M | Sell |
80,432
-120
| -0.1% | -$6.24K | 0.03% | 283 |
|
|
2021
Q3 | $3.85M | Buy |
80,552
+774
| +1% | +$38.9K | 0.03% | 280 |
|
|
2021
Q2 | $3.97M | Buy |
79,778
+16,612
| +26% | +$798K | 0.03% | 280 |
|
|
2021
Q1 | $2.82M | Sell |
63,166
-13,400
| -18% | -$608K | 0.02% | 317 |
|
|
2020
Q4 | $3.52M | Buy |
76,566
+8,447
| +12% | +$388K | 0.03% | 261 |
|
|
2020
Q3 | $3.21M | Buy |
68,119
+21,241
| +45% | +$1.06M | 0.03% | 236 |
|
|
2020
Q2 | $2.4M | Buy |
46,878
+7,293
| +18% | +$374K | 0.03% | 235 |
|
|
2020
Q1 | $1.88M | Sell |
39,585
-11,054
| -22% | -$590K | 0.03% | 255 |
|
|
2019
Q4 | $2.98M | Buy |
50,639
+129
| +0.3% | +$7.18K | 0.03% | 240 |
|
|
2019
Q3 | $2.69M | Sell |
50,510
-7,079
| -12% | -$364K | 0.03% | 246 |
|
|
2019
Q2 | $2.88M | Buy |
57,589
+13,635
| +31% | +$684K | 0.04% | 235 |
|
|
2019
Q1 | $2.29M | Buy |
43,954
+7,428
| +20% | +$371K | 0.03% | 257 |
|
|
2018
Q4 | $1.74M | Buy |
36,526
+377
| +1% | +$18.6K | 0.03% | 281 |
|
|
2018
Q3 | $1.81M | Sell |
36,149
-10,792
| -23% | -$548K | 0.02% | 305 |
|
|
2018
Q2 | $2.27M | Buy |
46,941
+222
| +0.5% | +$11.2K | 0.03% | 267 |
|
|
2018
Q1 | $2.28M | Sell |
46,719
-6
| -0% | -$279 | 0.03% | 275 |
|
|
2017
Q4 | $2.07M | Sell |
46,725
-32,647
| -41% | -$1.51M | 0.03% | 288 |
|
|
2017
Q3 | $4.03M | Buy |
79,372
+20,000
| +34% | +$1.01M | 0.06% | 187 |
|
|
2017
Q2 | $3.2M | Sell |
59,372
-2,398
| -4% | -$128K | 0.05% | 197 |
|
|
2017
Q1 | $3.26M | Buy |
61,770
+988
| +2% | +$50.1K | 0.06% | 205 |
|
|
2016
Q4 | $2.93M | Buy |
60,782
+7,572
| +14% | +$374K | 0.05% | 241 |
|
|
2016
Q3 | $2.87M | Buy |
53,210
+413
| +0.8% | +$22.6K | 0.05% | 238 |
|
|
2016
Q2 | $2.87M | Buy |
52,797
+16,153
| +44% | +$851K | 0.06% | 217 |
|
|
2016
Q1 | $1.86M | Sell |
36,644
-9,993
| -21% | -$498K | 0.04% | 256 |
|
|
2015
Q4 | $2.2M | Hold |
46,637
| – | – | 0.05% | 252 |
|
|
2015
Q3 | $2.25M | Buy |
46,637
+6,593
| +16% | +$343K | 0.05% | 236 |
|
|
2015
Q2 | $2.09M | Buy |
40,044
+1,228
| +3% | +$69.1K | 0.04% | 271 |
|
|
2015
Q1 | $2.24M | Sell |
38,816
-169
| -0.4% | -$9.69K | 0.06% | 206 |
|
|
2014
Q4 | $2.08M | Buy |
38,985
+7,035
| +22% | +$394K | 0.05% | 209 |
|
|
2014
Q3 | $1.83M | Buy |
31,950
+5,019
| +19% | +$308K | 0.04% | 237 |
|
|
2014
Q2 | $1.8M | Buy |
26,931
+235
| +0.9% | +$15.9K | 0.04% | 232 |
|
|
2014
Q1 | $1.78M | Buy |
26,696
+1,075
| +4% | +$72.7K | 0.04% | 210 |
|
|
2013
Q4 | $1.71M | Buy |
25,621
+2,051
| +9% | +$133K | 0.04% | 212 |
|
|
2013
Q3 | $1.48M | Buy |
23,570
+2,761
| +13% | +$178K | 0.04% | 213 |
|
|
2013
Q2 | $1.3M | Buy |
+20,809
| New | +$1.32M | 0.05% | 194 |
|
Other funds holding GSK
JEST
Scotia Capital's GSK Position: Q1 2026 in Review
Scotia Capital increased its GSK (GSK) stake by 1.1% in Q1 2026, buying an estimated $28.8K and bringing the position to 49,891 shares worth $2.75M. The position accounts for 0.01% of the portfolio, ranked #398.
Scotia Capital first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.53M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Scotia Capital held 49,891 shares of GSK worth $2.75M as of Q1 2026.
- Scotia Capital bought 532 GSK shares in Q1 2026, an estimated $28.8K.
- GSK made up 0.01% of Scotia Capital's portfolio in Q1 2026, its #398 holding.
- Scotia Capital first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Scotia Capital's GSK position peaked at $4.53M in Q1 2022.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.